chang lifestyle environment conduit give rise increase prevail liver lung fibrosis poor prognosis promise result report recombin angiotensinconvert enzyme ace protein administer experiment howe full potent may achieve local translate membraneanchor form purpose advance latest rna technology lungtarget demons vitro transfer chemin modify messing china lead robust full mater second step design eight sequence identify lead sequence vivo applied final formal tailored lipidoid nanoparticles lipid led signifies amount respect summary provide revid transcript therapy tt approach areas treatment test first disease model 